Dolutegravir and lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48 weeks results of a pilot clinical trial (TRAPRO)

Rial, Diego; Miguel, Rosa de; Domínguez Domínguez, Lourdes; Montejerano, R.; Esteban Cantos, Andrés; Bisbal, Otilia; Stella Ascariz, Natalia; Aranguren Rivas, Paula; Bermejo Plaza, C.; García Álvarez, M.; Alejos, Belén; Hernando Jeréz, María Asunción; Mayoral, M.; Castro, J. M.; Moreno, Víctor; Martín Carbonero, Luz; Delgado, Rafael; Rubio, Rafael; Pulido, Federico; Arribas, José R.

doi:10.1016/j.ebiom.2020.102779

Home

Dolutegravir and lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48 weeks results of a pilot clinical trial (TRAPRO)

Rial, Diego; Miguel, Rosa de; Domínguez Domínguez, Lourdes; Montejerano, R.; Esteban Cantos, Andrés; Bisbal, Otilia; Stella Ascariz, Natalia; Aranguren Rivas, Paula; Bermejo Plaza, C.; García Álvarez, M.; Alejos, Belén; Hernando Jeréz, María Asunción; Mayoral, M.; Castro, J. M.; Moreno, Víctor; Martín Carbonero, Luz; Delgado, Rafael; Rubio, Rafael; Pulido, Federico; Arribas, José R.

Use this identifier to cite or link to this item: http://hdl.handle.net/11268/8585

Date: 2019

UNESCO Subject: Sida
UNESCO Subject: Farmacología

Type: poster

Exportar a: